Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual

Jun 27, 2021 10:00 AM - Jul 01, 2021 4:30 PM

DIA 2021 Global Annual Meeting

DIA Global Annual Meeting - Opening DIAmond and Plenary Session

Session Chair(s)

Barbara  Lopez Kunz, MBA, MS, MSc

Barbara Lopez Kunz, MBA, MS, MSc

Director | Advisor | CEO

United States

We are excited to welcome you to the DIA 2021 Virtual Global Annual Meeting
Join us for the Global Annual Meeting Welcome Remarks, Keynote Address, and Opening DIAmond Session!

Keynote Address: Kenneth Frazier, JD, Chairman of the Board and Chief Executive Officer, Merck & Co.

For most of us, the novel coronavirus represents an unprecedented time in our lives. However, history is full of accounts of humans grappling with viral invaders, and the positive innovations and learnings that we derive from these circumstances. Ken Frazier, Chairman and CEO of Merck, reflects on the discoveries that were made during pandemics of the past and their durable effects on science and society. Mr. Frazier also discusses the adaptations and accelerations required to develop vaccines and therapeutics to address the current pandemic, and their implications for the future of drug development. The lasting transformations of the COVID-19 pandemic may yet to be fully characterized, but we know they will be documented in the history books.

Opening Plenary Panel: Combating Misinformation in Health and Health Care

The COVID-19 era has been characterized by a strong anti-science bias among large swaths of the public in many countries. This includes those who deny the existence of COVID; those who oppose vaccines based on spurious science, correlation that does not reflect causality, or an unsupported belief that vaccines are untrustworthy or harmful; those who believe that science comes from an elite that may not have the best interests of the general public at heart; and many others.

All of these beliefs pose significant challenges to public health efforts to contain the spread of COVID and encourage widespread vaccination. The problem is compounded by the tremendous amounts of misinformation that have been circulating since the beginning of the pandemic. This misinformation has been promulgated through many channels, particularly on social media. While reputable sources have made many attempts to remove or discredit such information, these efforts have been far from successful. People also continue to receive misinformation from family, friends, and public figures.

The panel will address the following high-level topics:
  • How does misinformation about health and health care spread? Why do people believe it?
  • What do we know about how to successfully help people identify and question misinformation?
  • Who is best positioned to counter misinformation about COVID, and what do we know about how to do so effectively?
  • Are there specific approaches to combating misinformation that can help address known disparities in health and health care, particularly those that are COVID-related?

Learning Objective : Identify two ways in which misinformation about health and health care spread; Identify one way in which to counter misinformation about COVID-19 effectively; Describe how known disparities in health and health care relate to the spread of misinformation about COVID-19.

Speaker(s)

Judith  Ng-Cashin, MD

Opening Remarks

Judith Ng-Cashin, MD

JNC Consulting, United States

Chief Executive Officer and President

Emer  Cooke, MBA, MSc

Honorary Co-Chair

Emer Cooke, MBA, MSc

The European Medicines Agency, Netherlands

Executive Director, Chair, ICMRA

Janet  Woodcock, MD

Honorary Co-Chair

Janet Woodcock, MD

United States

Retired, Principal Deputy Commissioner, FDA

Yasuhiro  Fujiwara, MD, PhD

Honorary Co-Chair

Yasuhiro Fujiwara, MD, PhD

Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Chief Executive

Michael  Rosenblatt, MD

Introduction of Keynote Speaker

Michael Rosenblatt, MD

Flagship Pioneering, United States

Chief Medical Officer

Kenneth  Frazier, JD

Keynote Speaker

Kenneth Frazier, JD

Merck & Co., Inc., United States

Chairman of the Board and Chief Executive Officer

Susan  Winckler, JD, RPh

Moderator: Combating Misinformation in Health and Health Care

Susan Winckler, JD, RPh

Reagan-Udall Foundation For the FDA, United States

Chief Executive Officer

Briony  Swire-Thompson

Panelist

Briony Swire-Thompson

Northeastern University Network Science Institute, United States

Senior Research Scientist, Lazer Lab

Brian  Southwell, PhD

Panelist

Brian Southwell, PhD

RTI International, United States

Senior Director, Science in the Public Sphere, Center for Communication Science

Melanie  Carr

Panelist

Melanie Carr

European Medicines Agency, Netherlands

Head of Stakeholders and Communication Division

Richardae  Araojo, PharmD, MS

Panelist

Richardae Araojo, PharmD, MS

FDA, United States

Associate Commissioner for Minority Health, Director, Office of Minority Health

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.